These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


141 related items for PubMed ID: 10389964

  • 1. Management of sulfonylurea ingestions.
    Spiller HA.
    Pediatr Emerg Care; 1999 Jun; 15(3):227-30. PubMed ID: 10389964
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Safety of subcutaneous octreotide in patients with sulfonylurea-induced hypoglycemia and congestive heart failure.
    Vallurupalli S.
    Ann Pharmacother; 2010 Feb; 44(2):387-90. PubMed ID: 20118140
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Octreotide for paediatric sulfonylurea poisonings.
    Osterhoudt KC.
    J Paediatr Child Health; 2009 Feb; 45(7-8):473. PubMed ID: 19712185
    [No Abstract] [Full Text] [Related]

  • 11. Are one or two dangerous? Sulfonylurea exposure in toddlers.
    Little GL, Boniface KS.
    J Emerg Med; 2005 Apr; 28(3):305-310. PubMed ID: 15769574
    [Abstract] [Full Text] [Related]

  • 12. Octreotide for sulfonylurea-induced hypoglycemia following overdose.
    Carr R, Zed PJ.
    Ann Pharmacother; 2002 Nov; 36(11):1727-32. PubMed ID: 12398568
    [Abstract] [Full Text] [Related]

  • 13. Case files of the Medical Toxicology Fellowship Training Program at the Children's Hospital of Philadelphia: a pediatric exploratory sulfonylurea ingestion.
    Calello DP, Kelly A, Osterhoudt KC.
    J Med Toxicol; 2006 Mar; 2(1):19-24. PubMed ID: 18072108
    [No Abstract] [Full Text] [Related]

  • 14. Sulfonylurea-induced hypoglycaemia: use of octreotide.
    Hanchard B, Boulouffe C, Vanpee D.
    Acta Clin Belg; 2009 Mar; 64(1):56-8. PubMed ID: 19317242
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Sulfonylurea intoxication at a tertiary care paediatric hospital.
    Glatstein M, Garcia-Bournissen F, Scolnik D, Koren G.
    Can J Clin Pharmacol; 2010 Mar; 17(1):e51-6. PubMed ID: 20124602
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Octreotide in children with hypoglycaemia due to sulfonylurea ingestion.
    Rath S, Bar-Zeev N, Anderson K, Fahy R, Roseby R.
    J Paediatr Child Health; 2008 Jun; 44(6):383-4. PubMed ID: 18476935
    [Abstract] [Full Text] [Related]

  • 20. Use of octreotide to treat prolonged sulfonylurea-induced hypoglycemia in a patient with chronic renal failure.
    Nzerue CM, Thomas J, Volcy J, Edeki T.
    Int J Artif Organs; 2003 Jan; 26(1):86-9. PubMed ID: 12602474
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.